- $1.05bn
- $2.47bn
- $3.29bn
- 97
- 98
- 20
- 83
Annual income statement for Cimpress, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,481 | 2,576 | 2,888 | 3,080 | 3,292 |
| Cost of Revenue | |||||
| Gross Profit | 1,232 | 1,276 | 1,395 | 1,439 | 1,597 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,425 | 2,501 | 2,840 | 3,016 | 3,045 |
| Operating Profit | 56 | 75.2 | 47.3 | 64.1 | 247 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3 | -63.6 | 9.33 | -30.2 | 128 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -29.5 | -82.5 | -50.6 | -186 | 178 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 83.4 | -85.2 | -54.3 | -186 | 174 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 83.4 | -85.2 | -54.3 | -186 | 174 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.64 | -1 | -1.96 | -5.86 | 6.49 |